Back
Apellis Pharmaceuticals Stock Price Chart
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
APLS
Apellis Pharmaceuticals
Last Price:
$17.50
Seasonality Move:
-4.83%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.98 | Sell |
| 20-day SMA: | 18.5 | Sell |
| 50-day SMA: | 21.53 | Sell |
| 200-day SMA: | 29.57 | Sell |
| 8-day EMA: | 18.39 | Sell |
| 20-day EMA: | 19.01 | Sell |
| 50-day EMA: | 21.4 | Sell |
| 200-day EMA: | 29.85 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.89 | Sell |
| Relative Strength Index (14 RSI): | 34.14 | Sell |
| Chaikin Money Flow: | -2514635 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.72 - 19.62) | Sell |
| Bollinger Bands (100): | (20.77 - 31.31) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 17.30 while APLS 8-day simple moving average is 18.98, which is a Sell signal.
-
The stock price of APLS is 17.30 while Apellis Pharmaceuticals 20-day SMA is 18.50, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day simple moving average is 21.53 while APLS share price is 17.30, making it a Sell technically.
-
APLS stock price is 17.30 and Apellis Pharmaceuticals 200-day simple moving average is 29.57, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $17.30. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
2.2B
Price in USD:
17.30
Share Volume:
3M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
43.99
52-Week Low:
16.65
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 17.30 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 17.30 while APLS 8-day exponential moving average is 18.39, which is a Sell signal.
-
The stock price of APLS is 17.30 while Apellis Pharmaceuticals 20-day EMA is 19.01, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day exponential moving average is 21.40 while APLS share price is 17.30, making it a Sell technically.
-
APLS stock price is 17.30 and Apellis Pharmaceuticals 200-day simple moving average is 29.85, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.20 per share, a decrease this year of $0.20 per share, and an increase next year of $1.30 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is -0.89, suggesting Apellis Pharmaceuticals is a Sell
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 34.14, which suggest Apellis Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (17.72 - 19.62), which suggest Apellis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (20.77 - 31.31), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.